| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1367-5931(99)00049-6 |
| P698 | PubMed publication ID | 10679371 |
| P2093 | author name string | Way JC | |
| P2860 | cites work | Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region | Q24685870 |
| Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand | Q27747759 | ||
| Structure of human methionine aminopeptidase-2 complexed with fumagillin | Q27766008 | ||
| CRM1 is an export receptor for leucine-rich nuclear export signals | Q27860453 | ||
| Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor | Q28368986 | ||
| Anatomy of hot spots in protein interfaces | Q29616238 | ||
| The acetylation of hemoglobin by aspirin. In vitro and in vivo | Q35194461 | ||
| Allergy to Penicillin and Related Antibiotics: Antigenic and Immunochemical Mechanism | Q39931073 | ||
| Aspirin-like molecules that covalently inactivate cyclooxygenase-2. | Q41032686 | ||
| FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes | Q41119643 | ||
| Penicillins and cephalosporins are active site-directed acylating agents: evidence in support of the substrate analogue hypothesis | Q41531491 | ||
| The reaction of penicillin with proteins | Q42555267 | ||
| Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs | Q45781834 | ||
| From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus | Q46189813 | ||
| Inhibiting the assembly of protein-protein interfaces. | Q47829688 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases | Q56552583 | ||
| Rational approaches to chemotherapy: antisickling agents | Q70844740 | ||
| Stereospecific Alkylation with Asymmetric Reagents | Q72046774 | ||
| Studies on the direct neutral penicilloylation of functional groups occurring on proteins | Q72122064 | ||
| Sickle Cell (II): Many Agents Near Trials | Q72625863 | ||
| Discovering high-affinity ligands for proteins | Q73904870 | ||
| NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain | Q78222286 | ||
| P433 | issue | 1 | |
| P921 | main subject | protein-protein interaction | Q896177 |
| P304 | page(s) | 40-46 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Current Opinion in Chemical Biology | Q15758415 |
| P1476 | title | Covalent modification as a strategy to block protein-protein interactions with small-molecule drugs | |
| P478 | volume | 4 |
| Q24649147 | Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins |
| Q38011256 | Drug discovery for a new generation of covalent drugs |
| Q24651974 | Electrophilic affibodies forming covalent bonds to protein targets |
| Q35485376 | Fluorescence detection of GDP in real time with the reagentless biosensor rhodamine-ParM. |
| Q51533605 | Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain. |
| Q44561165 | Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction |
| Q46691166 | Inhibition of the calcineurin-NFAT interaction by small organic molecules reflects binding at an allosteric site |
| Q35730955 | New Frontiers in Druggability |
| Q38693434 | New drug design with covalent modifiers. |
| Q57976568 | Sec, drugs and rock’n’roll: antibiotic targeting of bacterial protein translocation |
| Q29617758 | Small-molecule inhibitors of protein-protein interactions: progressing towards the dream |
| Q42245644 | Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2. |
| Q38931379 | Targeted Covalent Inhibitors for Drug Design. |
Search more.